Topics
Technologies
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long...
MUMBRA, India — The afternoon sun shines on the woman in a commuter-town café, highlighting her almond-shaped eyes and pale...
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In...
Policies
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to...
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents...
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in...
When I began to write a book about bioethics and the rules-based international order, the idea that the world was...
Society
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It...
Who gets to be "hot" in America? And, at what cost?
Some young men are pushing beauty boundaries with guidance...
Millions of people struggle to become pregnant in the U.S. And in 2024, fertility rates reached a new low, according...
"Jennifer Doudna" by Duncan Hull for the Royal Society via Wikimedia Commons licensed under CC by SA 3.0
Soon...
Perspectives
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The...
Since I started working to understand the radicalization of young men, I’ve gotten asked the same question everywhere I go...
Prospective parents are being marketed genetic tests that claim to predict which IVF embryo will grow into the tallest, smartest...
Joseph Yracheta: The Native Biodata Consortium is the first nonprofit data and sample repository within the geographic bounds and legal...